Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
RFA-NS-25-024The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) are announcing a new funding opportunity for scientific research using data from expanded access to investigational drugs or biological products for patients with amyotrophic lateral sclerosis (ALS). This opportunity focuses on those who cannot join regular clinical trials. The resea…
The National Institute of Neurological Disorders and Stroke (NINDS) and the Office of the Director, National Institutes of Health (OD), intend to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for the conduct of scientific research utilizi…
Funding Source
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers